Bayesian <mml:math altimg="si67.gif" display="inline" overflow="scroll" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.elsevier.com/xml/ja/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd"><mml:mi>D</mml:mi></mml:math>-optimal designs for the two parameter logistic mixed effects model, Computational Statistics & Data Analysis, vol.71, pp.1066-1076, 2014. ,
DOI : 10.1016/j.csda.2013.07.040
Handbook of Mathematical Functions with Formulas, Graphs, and Mathematical Tables, 1964. ,
Experimental design and efficient parameter estimation in population pharmacokinetics, Journal of Pharmacokinetics and Biopharmaceutics, vol.46, issue.4, pp.347-360, 1990. ,
DOI : 10.1007/BF01062273
Optimum Experimental Designs, with SAS, 2007. ,
Elemental information matrices and optimal experimental design for generalized regression models, Journal of Statistical Planning and Inference, vol.144, pp.81-91, 2014. ,
DOI : 10.1016/j.jspi.2012.09.012
Relative curvature measures of nonlinearity, Journal of the Royal Statistical Society: Series B, vol.42, pp.1-25, 1980. ,
Fisher information matrix for nonlinear mixed effects multiple response models: Evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model, Statistics in Medicine, vol.60, issue.14, pp.1940-1956, 2009. ,
DOI : 10.1111/j.0006-341X.2004.00148.x
URL : https://hal.archives-ouvertes.fr/inserm-00371363
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0, Computer Methods and Programs in Biomedicine, vol.98, issue.1, pp.55-65, 2010. ,
DOI : 10.1016/j.cmpb.2009.09.012
URL : https://hal.archives-ouvertes.fr/inserm-00431457
DESIGN OF EXPERIMENTS IN NON-LINEAR SITUATIONS, Biometrika, vol.46, issue.1-2, pp.77-90, 1959. ,
DOI : 10.1093/biomet/46.1-2.77
Practical considerations for optimal designs in clinical dose finding studies, Statistics in Medicine, vol.27, issue.6, pp.7-8, 2010. ,
DOI : 10.1002/sim.3802
Locally Optimal Designs for Estimating Parameters, The Annals of Mathematical Statistics, vol.24, issue.4, pp.586-602, 1953. ,
DOI : 10.1214/aoms/1177728915
Using Spherical???Radial Quadrature to Fit Generalized Linear Mixed Effects Models, Journal of Computational and Graphical Statistics, vol.11, issue.3, pp.639-659, 2002. ,
DOI : 10.1198/106186002439
Curvatures for Parameter Subsets in Nonlinear Regression, The Annals of Statistics, vol.14, issue.4, pp.1399-1418, 1986. ,
DOI : 10.1214/aos/1176350166
Optimal sampling times for pharmacokinetic experiments, Journal of Pharmacokinetics and Biopharmaceutics, vol.10, issue.6, pp.739-756, 1981. ,
DOI : 10.1007/BF01070904
Overview of model-building strategies in population PK/PD analyses: 2002???2004 literature survey, British Journal of Clinical Pharmacology, vol.4, issue.5, pp.603-612, 2007. ,
DOI : 10.1007/s10928-006-9046-9
URL : https://hal.archives-ouvertes.fr/inserm-00159122
Efficient experimental designs for sigmoidal growth models, Journal of Statistical Planning and Inference, vol.138, issue.1, pp.2-17, 2008. ,
DOI : 10.1016/j.jspi.2007.05.027
URL : http://dx.doi.org/10.17877/DE290R-6731
Influence of Covariance Between Random Effects in Design for Nonlinear Mixed-Effect Models with an Illustration in Pediatric Pharmacokinetics, Journal of Biopharmaceutical Statistics, vol.7, issue.4, pp.471-492, 2014. ,
DOI : 10.2165/00003088-200847040-00002
URL : https://hal.archives-ouvertes.fr/inserm-00769812
Theory of Optimal Experiments, 1972. ,
Optimal Design for Nonlinear Response Models, 2014. ,
A Rapidly Convergent Descent Method for Minimization, The Computer Journal, vol.6, issue.2, pp.163-168, 1963. ,
DOI : 10.1093/comjnl/6.2.163
Adaptive Optimal Design for Bridging Studies with an Application to Population Pharmacokinetic Studies, Pharmaceutical Research, vol.34, issue.6, pp.1530-1543, 2012. ,
DOI : 10.1007/s11095-011-0659-3
Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, 2006. ,
Some Modified Matrix Eigenvalue Problems, SIAM Review, vol.15, issue.2, pp.318-334, 1973. ,
DOI : 10.1137/1015032
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.454.9868
Calculation of Gauss quadrature rules, Mathematics of Computation, vol.23, issue.106, pp.221-230, 1969. ,
DOI : 10.1090/S0025-5718-69-99647-1
Fast Computation of Designs Robust to Parameter Uncertainty for Nonlinear Settings, Technometrics, vol.51, issue.1, pp.88-95, 2009. ,
DOI : 10.1198/TECH.2009.0009
Design evaluation and optimization for models of hepatitis C viral dynamics, Statistics in Medicine, vol.38, issue.18, pp.1045-1056, 2011. ,
DOI : 10.1002/sim.4191
URL : https://hal.archives-ouvertes.fr/inserm-00615142
Practical Identifiability of HIV Dynamics Models, Bulletin of Mathematical Biology, vol.48, issue.8, pp.2493-2513, 2007. ,
DOI : 10.1007/s11538-007-9228-7
URL : https://hal.archives-ouvertes.fr/inserm-00204273
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic???pharmacodynamic models, Computer Methods and Programs in Biomedicine, vol.86, issue.1, pp.51-61, 2007. ,
DOI : 10.1016/j.cmpb.2007.01.004
Bayesian Experimental Design for Nonlinear Mixed-Effects Models with Application to HIV Dynamics, Biometrics, vol.50, issue.1, pp.25-33, 2004. ,
DOI : 10.1038/373117a0
Design of population studies of HIV dynamics Deterministic and Stochastic Models of AIDS Epidemics and HIV Infections with Intervention, pp.525-548, 2005. ,
Designs for population pharmacodynamics: Value of pharmacokinetic data and population analysis, Journal of Pharmacokinetics and Biopharmaceutics, vol.76, issue.3, pp.333-353, 1991. ,
DOI : 10.1007/BF03036255
Constructing optimal designs for fitting pharmacokinetic models, Statistics and Computing, vol.9, issue.3, pp.209-218, 1999. ,
DOI : 10.1023/A:1008922030873
Design of cross-over trials for pharmacokinetic studies, Journal of Statistical Planning and Inference, vol.78, issue.1-2, pp.307-316, 1999. ,
DOI : 10.1016/S0378-3758(98)00221-3
Comparison of some practical sampling strategies for population pharmacokinetic studies, Journal of Pharmacokinetics and Biopharmaceutics, vol.19, issue.2, pp.245-263, 1996. ,
DOI : 10.1007/BF02353491
The equivalence of two extremum problems, Journal canadien de math??matiques, vol.12, issue.0, pp.363-366, 1960. ,
DOI : 10.4153/CJM-1960-030-4
Maximum likelihood estimation in nonlinear mixed effects models, Computational Statistics & Data Analysis, vol.49, issue.4, pp.1020-1038, 2005. ,
DOI : 10.1016/j.csda.2004.07.002
Model-based Drug Development, Clinical Pharmacology & Therapeutics, vol.33, issue.1, pp.21-32, 2007. ,
DOI : 10.1038/sj.clpt.6100235
Optimal design for population pk/pd models, Tatra Mountains Mathematical Publications, vol.51, issue.1, pp.115-130, 2012. ,
DOI : 10.2478/v10127-012-0012-1
Model and Its Application in Clinical Trials, Journal of Biopharmaceutical Statistics, vol.19, issue.2, pp.360-385, 2009. ,
DOI : 10.1002/sim.2213
Nonlinear Mixed Effects Models for Repeated Measures Data, Biometrics, vol.46, issue.3, pp.673-687, 1990. ,
DOI : 10.2307/2532087
Finding the observed information matrix when using the EM algorithm, Journal of the Royal Statistical Society Series B, vol.44, pp.226-233, 1982. ,
Adaptive Bayesian compound designs for dose finding studies, Journal of Statistical Planning and Inference, vol.142, issue.6, pp.1480-1492, 2012. ,
DOI : 10.1016/j.jspi.2011.12.029
Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe???s European Federation of Pharmaceutical Industries and Associations Members, CPT: Pharmacometrics and Systems Pharmacology 2, p.46, 2013. ,
DOI : 10.1007/s11095-011-0659-3
Optimal design in random-effects regression models, Biometrika, vol.84, issue.2, pp.429-442, 1997. ,
DOI : 10.1093/biomet/84.2.429
Approximations of the Fisher information for the construction of efficient experimental designs in nonlinear mixed effects models, 2012. ,
Some Considerations on the Fisher Information in Nonlinear Mixed Effects Models, Proceedings of the 9th International Workshop in Model-Oriented Design and Analysis. Physica Verlag, pp.129-136, 2010. ,
DOI : 10.1007/978-3-7908-2410-0_17
Spherical-Radial Integration Rules for Bayesian Computation, Journal of the American Statistical Association, vol.38, issue.438, pp.664-674, 1997. ,
DOI : 10.1080/01621459.1997.10474018
Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models, Statistics in Medicine, vol.30, issue.11-12, pp.11-12, 2012. ,
DOI : 10.1002/sim.4191
URL : https://hal.archives-ouvertes.fr/inserm-00629594
Semimechanistic Pharmacokinetic/Pharmacodynamic Model for Assessment of Activity of Antibacterial Agents from Time-Kill Curve Experiments, Antimicrobial Agents and Chemotherapy, vol.51, issue.1, pp.128-136, 2007. ,
DOI : 10.1128/AAC.00604-06
Methods and software tools for design evaluation for population pharmacokineticspharmacodynamics studies, British Journal of Clinical Pharmacology, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-00978789
Direct calculation of the information matrix via the EM, Journal of the Royal Statistical Society: Series B (Statistical Methodology), vol.61, issue.2, pp.479-482, 1999. ,
DOI : 10.1111/1467-9868.00188
Estimating drug efficacy and viral dynamic parameters: HIV and HCV, Statistics in Medicine, vol.43, issue.23, pp.4647-4657, 2008. ,
DOI : 10.1002/sim.3116
Non-Linear Mixed Effects Modeling ??? From Methodology and Software Development to Driving Implementation in Drug Development Science, Journal of Pharmacokinetics and Pharmacodynamics, vol.72, issue.6, pp.161-183, 2005. ,
DOI : 10.1007/s10928-005-0062-y
Approximations to the log-likelihood function in the nonlinear mixed-effects model, Journal of Computational and Graphical Statistics, vol.4, pp.12-35, 1995. ,
Performance Comparison of Various Maximum Likelihood Nonlinear Mixed-Effects Estimation Methods for Dose???Response Models, The AAPS Journal, vol.14, issue.3, pp.420-432, 2012. ,
DOI : 10.1208/s12248-012-9349-2
URL : https://hal.archives-ouvertes.fr/inserm-00709829
Numerical Recipes in C, The Art of Scientific Computing, 1992. ,
Penalized optimal designs for dose-finding, Journal of Statistical Planning and Inference, vol.140, issue.1, pp.283-296, 2010. ,
DOI : 10.1016/j.jspi.2009.07.012
URL : https://hal.archives-ouvertes.fr/hal-00416014
Design in nonlinear mixed effects models: Optimization using the Fedorov???Wynn algorithm and power of the Wald test for binary covariates, Statistics in Medicine, vol.39, issue.28, pp.5162-5179, 2007. ,
DOI : 10.1002/sim.2910
URL : https://hal.archives-ouvertes.fr/hal-00263513
Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics, Journal of Biopharmaceutical Statistics, vol.13, issue.2, pp.209-227, 2003. ,
DOI : 10.1081/BIP-100101009
Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics, Statistics in Medicine, vol.26, issue.6, pp.2623-2639, 2002. ,
DOI : 10.1002/sim.1041
Implementation and Evaluation of the SAEM Algorithm for Longitudinal Ordered Categorical Data with an Illustration in Pharmacokinetics???Pharmacodynamics, The AAPS Journal, vol.13, issue.1, pp.44-53, 2011. ,
DOI : 10.1208/s12248-010-9238-5
URL : https://hal.archives-ouvertes.fr/hal-00637400
Estimation of population characteristics of pharmacokinetic parameters from routine clinical data, Journal of Pharmacokinetics and Biopharmaceutics, vol.15, issue.5, pp.445-479, 1977. ,
DOI : 10.1007/BF01061728
Modelling of individual pharmacokinetics for computer-aided drug dosage, Computers and Biomedical Research, vol.5, issue.5, pp.411-459, 1972. ,
DOI : 10.1016/0010-4809(72)90051-1
Biostatistics and Pharmacometrics: Quantitative Sciences to Propel Drug Development Forward, Clinical Pharmacology & Therapeutics, vol.46, issue.2, pp.141-144, 2010. ,
DOI : 10.2307/749110
Nonlinear regression Encyclopedia of Environmetrics 3, pp.1405-1411, 2002. ,
Application of Quasi-Newton algorithms in optimal design. Workshop of Population Optimum Design of Experiments, 2010. ,
CPT: Pharmacometrics and Systems Pharmacology, CPT: Pharmacometrics & Systems Pharmacology, vol.1, issue.9, p.8, 2012. ,
DOI : 10.1038/psp.2012.8
Evaluation of estimation methods for repeated time to event models: application to analysis of bone events during treatment of Gaucher Disease, 2012. ,
Handling below limit of quantification data in optimal trial design, 2012. ,
Identifiabilities and nonlinearities, Nonlinear Systems 1, pp.111-143, 1995. ,
DOI : 10.1007/978-1-4615-2047-4_4
Identification of Parametric Models from Experimental Data, 2007. ,
Laplace's approximation for nonlinear mixed models, Biometrika, vol.80, issue.4, pp.791-795, 1993. ,
DOI : 10.1093/biomet/80.4.791
Results in the theory and construction of D-optimum designs, Journal of the Royal Statistical Society Series B, vol.34, pp.133-147, 1972. ,